Products – Flovid 2
Under Development, FDA Approval Required.
In Spring 2020, FLOVID-20 non-human primate studies were performed at the United States National Laboratory, University of Texas Medical Branch, Galveston
Treated primates resisted infection. Control primates developed COVID pneumonia.
MANUFACTURING FOR CLINICAL TESTING
PHASE I/II CLINICAL TESTING